Search - tctmd.com

Displaying 1 - 20 of 126

Sort: Relevancy | Date

Presentation THT 2026

Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF

Presenter: Sheldon E. Litwin

March 04, 2026

Presentation THT 2026

Managing Afib: Is There a Difference in HFpEF vs HFrEF

Presenter: Nassir F. Marrouche

March 03, 2026

Presentation THT 2026

Invasive exercise hemodynamics following transcatheter pulmonary artery banding (tPAB) for HFrEF.

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Presenter: Rami Kahwash

March 03, 2026

Presentation THT 2026

Myocardial Intramural Remodeling by Tranvenous Tether: MIRTH

Presenter: Chris Bruce

March 03, 2026

Presentation THT 2026

Cinching the Papillary Muscle Bases To Remodel the LV: Vsling

Presenter: Horst Sievert

March 03, 2026

Presentation THT 2026

Pulmonary Artery Banding to Unload the LV: The RESTORE Medical Study

Presenter: Sean P. Pinney

March 03, 2026

Presentation THT 2026

BioVentrix: Revival of the REVIVE-HF Study

Presenter: Ori Ben-Yehuda

March 03, 2026

Presentation THT 2026

Passive Smartwatch-Derived Physiology Predicts Biomarker-Defined Instability in Ambulatory HFrEF: Results From the TRIBE-HF II Study

Presenter: Rohan Goswami

March 03, 2026

Presentation THT 2026

Cardiac Dimensions - EMPOWER Trial

Presenter: Scott M. Lilly

March 03, 2026

Presentation THT 2026

AccuCinch Transcatheter Left Ventricular Restoration (TLVR) System and the CORCINCH-HF Study

Presenter: Ulrich P. Jorde

March 03, 2026

Presentation THT 2026

Pathophysiology of HFrEF in Patients with Enlarged Ventricles — Rationale for Ventricular Reconstruction

Presenter: Eric Jose Velazquez

March 03, 2026

Presentation THT 2026

Beyond the Heart and Nerves: Diaphragmatic Stimulation for HFrEF - Viscardia

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Barostimulation Therapy for HFrEF

Presenter: Philip Adamson, MD

March 03, 2026

Presentation THT 2026

RECOVER-HF Double-Blinded, Sham-Controlled Pilot Study: Impact of Synchronized Diaphragmatic Stimulation in HFrEF Patients

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Presenter: Amish Raval

March 02, 2026

Presentation TCT 2025

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

Presenter: Dawood Shehzad

October 28, 2025

Presentation TCT 2025

Unmet Needs in HFrEF: The Clinical Opportunity

Presenter: Stefan Verheye

October 27, 2025

Presentation TCT 2025

TCT 538: Real-World Outcomes Following Cardiac Contractility Modulation in HFrEF: A Single-Center Retrospective Experience

Presenter: Kareem Elgendi

October 27, 2025

Advertisement

Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF

Managing Afib: Is There a Difference in HFpEF vs HFrEF

Invasive exercise hemodynamics following transcatheter pulmonary artery banding (tPAB) for HFrEF.

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Myocardial Intramural Remodeling by Tranvenous Tether: MIRTH

Cinching the Papillary Muscle Bases To Remodel the LV: Vsling

Pulmonary Artery Banding to Unload the LV: The RESTORE Medical Study

BioVentrix: Revival of the REVIVE-HF Study

Passive Smartwatch-Derived Physiology Predicts Biomarker-Defined Instability in Ambulatory HFrEF: Results From the TRIBE-HF II Study

Cardiac Dimensions - EMPOWER Trial

AccuCinch Transcatheter Left Ventricular Restoration (TLVR) System and the CORCINCH-HF Study

Pathophysiology of HFrEF in Patients with Enlarged Ventricles — Rationale for Ventricular Reconstruction

Beyond the Heart and Nerves: Diaphragmatic Stimulation for HFrEF - Viscardia

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Barostimulation Therapy for HFrEF

RECOVER-HF Double-Blinded, Sham-Controlled Pilot Study: Impact of Synchronized Diaphragmatic Stimulation in HFrEF Patients

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

Unmet Needs in HFrEF: The Clinical Opportunity

TCT 538: Real-World Outcomes Following Cardiac Contractility Modulation in HFrEF: A Single-Center Retrospective Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content